CHE Chemed

• None no insider bought on the open market
• $8.8M sold by 5 insiders outside a trading plan
• None no planned (10b5-1) sales

1. Insider
   Trade
   Value
   Traded, filed
2. Kevin J McNamara CEO
   Sale
   $1M 2,000 shares at $513.45 2.9% of stake
   Traded Sep 28 Filed Sep 30
   ↗
3. Kevin J McNamara CEO
   Sale
   $1M 2,000 shares at $501.40 2.8% of stake
   Traded Sep 18 Filed Sep 21
   ↗
4. Spencer S Lee executive vice president
   Sale
   $541K 1,000 shares at $541.04 6.7% of stake
   Traded Aug 21 Filed Aug 24
   ↗
5. Kevin J McNamara CEO
   Sale
   $1.1M 2,000 shares at $541.16 2.8% of stake
   Traded Aug 21 Filed Aug 24
   ↗
6. Kevin J McNamara CEO
   Sale
   $1.1M 2,000 shares at $539.51 2.8% of stake
   Traded Aug 3 Filed Aug 4
   ↗
7. Patrick P Grace Director
   Sale
   $101K 190 shares at $532.00 5.1% of stake
   Traded Jul 31 Filed Aug 3
   ↗
8. Andrea R Lindell Director
   Sale
   $603K 1,347 shares at $447.33 23% of stake
   Traded Jun 9 Filed Jun 10
   ↗
9. George J Walsh III Director
   Sale
   $219K 500 shares at $437.83 14% of stake
   Traded May 29 Filed May 29
   ↗
10. Patrick P Grace Director
    Sale
    $26K 60 shares at $425.78 1.8% of stake
    Traded May 8 Filed May 8
    ↗
11. Kevin J McNamara CEO
    Sale
    $842K 2,000 shares at $421.13 2.2% of stake
    Traded May 1 Filed May 4
    ↗
12. Kevin J McNamara CEO
    Sale
    $554K 1,500 shares at $369.37 1.6% of stake
    Traded Mar 27 Filed Mar 30
    ↗
13. Kevin J McNamara CEO
    Sale
    $806K 2,000 shares at $403.18 2.1% of stake
    Traded Mar 12 Filed Mar 13
    ↗
14. Kevin J McNamara CEO
    Sale
    $875K 2,000 shares at $437.55 2.1% of stake
    Traded Nov 24, 2025 Filed Nov 25, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 17 option exercises, 11 share withholdings for taxes, 7 stock grants, and 2 gifts.